Skip to main content

8. Reforming International Intellectual Property Rules for Global Equity and Access

Balancing Innovation with Access to Knowledge and Essential Goods​

International intellectual property (IP) rules, primarily governed by agreements like the WTO's TRIPS Agreement (Trade-Related Aspects of Intellectual Property Rights), aim to incentivize innovation by granting temporary monopolies (patents, copyrights) to creators and inventors. However, overly broad or stringent IP protections, particularly for essential goods like medicines, agricultural technologies, and educational materials, can hinder access in developing countries, stifle follow-on innovation, and exacerbate global inequalities.

Our platform advocates for reforming international IP rules to strike a better balance between rewarding innovation and ensuring equitable global access to knowledge, technology, and essential products. U.S. foreign policy should promote IP frameworks that foster innovation for the public good, rather than solely maximizing corporate profits or extending monopolies unnecessarily.

Key Principles for Reforming International IP Rules:​

  1. Prioritize Access to Essential Medicines:

    • Support and strengthen the use of TRIPS flexibilities (like compulsory licensing) that allow developing countries to produce or import affordable generic versions of patented life-saving medicines, especially during public health crises.
    • Oppose efforts in trade agreements ("TRIPS-plus" provisions) to impose stricter patent protections on pharmaceuticals than required by TRIPS, which delay generic competition and keep prices high.
    • Promote alternative R&D models for essential medicines (e.g., prize funds, public funding, patent pools) that de-link R&D costs from final product prices, ensuring affordability.

  2. Promote Access to Knowledge and Educational Materials:

    • Advocate for international copyright rules that include robust exceptions and limitations for education, research, libraries, archives, and access for people with disabilities (consistent with the Marrakesh Treaty).
    • Resist efforts to extend copyright terms excessively or impose overly restrictive digital rights management (DRM) measures that hinder legitimate access to information and culture.
    • Support open access publishing models and the sharing of publicly funded research globally.

  3. Ensure Fair Access to Agricultural Technologies:

    • Promote IP rules for seeds and agricultural biotechnologies that allow farmers, particularly smallholders in developing countries, to save, reuse, and exchange seeds, and that facilitate access to climate-resilient crops and sustainable farming techniques.
    • Prevent overly broad patents on plant varieties or genetic resources that could undermine food security or traditional farming practices.

  4. Facilitate Technology Transfer for Climate Solutions:

    • Support mechanisms within international climate agreements and trade deals to facilitate the transfer of clean energy and climate adaptation technologies to developing countries on fair and reasonable terms, potentially including flexible IP arrangements for essential climate technologies.

  5. Combat IP Abuse and Promote Competition:

    • Work internationally to address abuses of the patent system, such as "patent thickets" or "evergreening" tactics used to extend monopolies beyond their intended duration, particularly in the pharmaceutical sector.
    • Ensure IP rules do not unduly restrict competition or hinder the development of interoperable technologies.

Conclusion:​

Intellectual property rules should serve the broader goals of human progress, global equity, and sustainable development. While incentivizing innovation is important, current international IP frameworks often tilt too far towards protecting monopoly rights at the expense of access, particularly for essential goods in developing countries. U.S. foreign policy must champion a more balanced approach, reforming IP rules to ensure they foster innovation while promoting widespread access to medicines, knowledge, and technologies needed to address shared global challenges.